BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20605903)

  • 1. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
    Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
    Hadcock JR; Griffith DA; Iredale PA; Carpino PA; Dow RL; Black SC; O'Connor R; Gautreau D; Lizano JS; Ward K; Hargrove DM; Kelly-Sullivan D; Scott DO
    Biochem Biophys Res Commun; 2010 Apr; 394(2):366-71. PubMed ID: 20211605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.
    Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
    Pravdova E; Macho L; Fickova M
    Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet.
    Tulipano G; Vergoni AV; Soldi D; Muller EE; Cocchi D
    J Endocrinol; 2004 Nov; 183(2):289-98. PubMed ID: 15531717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.
    Chen W; Tang H; Liu H; Long L; Gong Z; Zheng J; Chi M; Xie Y; Zheng Z; Li S; Wang L
    Eur J Pharmacol; 2010 Jul; 637(1-3):178-85. PubMed ID: 20380831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats.
    Boozer CN; Leibel RL; Love RJ; Cha MC; Aronne LJ
    Metabolism; 2001 Aug; 50(8):889-93. PubMed ID: 11474475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonist.
    Hadcock JR; Carpino PA; Iredale PA; Dow RL; Gautreau D; Thiede L; Kelly-Sullivan D; Lizano JS; Liu X; Van Deusen J; Ward KM; O'Connor RE; Black SC; Griffith DA; Scott DO
    BMC Pharmacol; 2010 Aug; 10():9. PubMed ID: 20712891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction.
    Malloy VL; Krajcik RA; Bailey SJ; Hristopoulos G; Plummer JD; Orentreich N
    Aging Cell; 2006 Aug; 5(4):305-14. PubMed ID: 16800846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG
    Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate versus energy restriction: effects on weight loss, body composition and metabolism.
    Williams EA; Perkins SN; Smith NC; Hursting SD; Lane MA
    Ann Nutr Metab; 2007; 51(3):232-43. PubMed ID: 17587795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of physiological and pharmacological weight loss on adiponectin and leptin mRNA levels in the rat epididymal adipose tissue.
    Naderali EK; Fatani S; Telles M; Hunter L
    Eur J Pharmacol; 2008 Jan; 579(1-3):433-8. PubMed ID: 18155694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet.
    de Melo CL; Queiroz MG; Fonseca SG; Bizerra AM; Lemos TL; Melo TS; Santos FA; Rao VS
    Chem Biol Interact; 2010 Apr; 185(1):59-65. PubMed ID: 20188082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Sep; 460():1-414. PubMed ID: 12587016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
    Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
    Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
    Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity.
    White CL; Ishii Y; Mendoza T; Upton N; Stasi LP; Bray GA; York DA
    Peptides; 2005 Nov; 26(11):2331-8. PubMed ID: 15893404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
    Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD
    Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.